Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

67374 Press Releases
DateTitleCompany
12 Dec 11 Micromet’s Blinatumomab Produces High Rate of Durable Hematologic Complete Remissions in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Micromet,
Published by
Business Wire
12 Dec 11 Xeris Pharmaceuticals Closes US$1.5 Million Series A Financing with Central Texas Angel Network Xeris Pharmaceuticals Inc.,
Published by
Business Wire
12 Dec 11 Healogix Brings Unmatched Clarity to Health Care Decision Making with Adaptive ToolboxTM Healogix,
Published by
Business Wire
12 Dec 11 Allergan responds to Scottish Medicines Consortium decision regarding OZURDEX® (dexamethasone 700mcg intravitreal implant in applicator) Allergan
12 Dec 11 Clinical Professionals achieves top 50 ranking within the Sunday Times Fast Track 100 Clinical Professionals
12 Dec 11 Leading Medical Device Manufacturers of CE-Marked THV Devices Sign Contracts with ClinFlows ClinFlows,
Published by
PR Newswire
12 Dec 11 Insomnia: A No-Drug Solution? STX-Med,
Published by
PR Newswire
12 Dec 11 Arlington Medical Resources to Release Analysis of the Osteomyelitis Market in the United States Arlington Medical Resources,
Published by
Business Wire
12 Dec 11 Ganetespib Potently Inhibits Multiple Signaling Pathways Active in Breast Cancer Synta Pharmaceuticals Corp.,
Published by
Business Wire
12 Dec 11 Health Canada Approves Feraheme® (ferumoxytol) to Treat Iron Deficiency Anemia in Adults with Chronic Kidney Disease AMAG Pharmaceuticals Inc.,
Published by
Business Wire
12 Dec 11 AMAG Pharmaceuticals Announces Preliminary Data Regarding the Safety and Efficacy of a Single Infusion of 1020 mg Ferumoxytol (Feraheme®) in Patients with Iron Deficiency Anemia AMAG Pharmaceuticals Inc.,
Published by
Business Wire
12 Dec 11 ACT Announces Settlements and Filing of Preliminary Proxy Advanced Cell Technology Inc.,
Published by
Business Wire
12 Dec 11 Acetylon Announces Publication of Preclinical Pharmacokinetic, Pharmacodynamic and Bone Disease Results for ACY-1215 in Multiple Myeloma Acetylon Pharmaceuticals,
Published by
Business Wire
12 Dec 11 Acetylon Announces Addition of Catherine A. Wheeler MD as Vice President Clinical Development Acetylon Pharmaceuticals Inc.,
Published by
Business Wire
12 Dec 11 Multifaceted Repositioning Campaign for ZEVALIN® Unveiled at ASH 2011, Following Recent FDA Approval to Remove Bioscan Requirement Spectrum Pharmaceuticals,
Published by
Business Wire
12 Dec 11 BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies BioTime Inc.,
Published by
Business Wire
12 Dec 11 CytRx Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at ASH Conference CytRx Corporation,
Published by
Business Wire
12 Dec 11 First FDA-Approved Treatment for Myelofibrosis, Jakafi™ (ruxolitinib), Discussed in Multiple Presentations at 2011 ASH Annual Meeting Incyte Corporation,
Published by
Business Wire
12 Dec 11 Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer Geron Corporation,
Published by
Business Wire
12 Dec 11 Medidata Solutions Broadens CRO Partner Accreditations to Field Increasing Product Demand Medidata Solutions,
Published by
Business Wire
12 Dec 11 Synageva BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012 Synageva BioPharma,
Published by
Business Wire
12 Dec 11 Merganser Biotech Announces Signing of Option to License Minihepcidin Technology from UCLA Merganser Biotech Inc.,
Published by
Business Wire
12 Dec 11 Following a Near-Term Market Decline, the Launch of New Acute Therapies and Increasing Uptake of Allergan’s Botox Will Drive the Migraine Drug Market to Increase to $4.4 Billion in 2020 Decision Resources,
Published by
Business Wire
12 Dec 11 Emergent BioSolutions to Participate in January 2012 Investor Conferences Emergent BioSolutions Inc.,
Published by
Business Wire
12 Dec 11 Through 2020, Generic Erosion of Blockbuster Agents Will Be a Major Contributor to a Nearly $6 Billion Decrease in the Dyslipidemia Drug Market Decision Resources,
Published by
Business Wire
12 Dec 11 Truveris Expands Leadership Team with Additions to the Board Truveris,
Published by
Business Wire
12 Dec 11 The Combined Markets for Drugs Used in the Treatment and Prophylaxis of Venous Thromboembolism Will Increase from $3.4 Billion in 2010 to $4.7 Billion in 2020 Decision Resources,
Published by
Business Wire
12 Dec 11 U.S. Patients Are Extremely Happy with Their Doctors, New Study Shows DrScore.com,
Published by
Business Wire
12 Dec 11 Celldex Therapeutics Presents Novel Preclinical Data on CDX-1127 at the American Society of Hematology Meeting in San Diego Celldex Therapeutics Inc.,
Published by
Business Wire
12 Dec 11 ICON Acquires BeijingWits Medical Consulting Ltd ICON plc,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.